Bioceltix

Bioceltix Fixed Asset Turnover

Fixed Asset Turnover of Bioceltix (BCX.WA) as of Oct 21, 2026.

Fixed Asset Turnover

-

Last updated:

Fixed Asset Turnover of Bioceltix is 2026 - . Fixed Asset Turnover of Bioceltix was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioceltix Stock analysis

What does Bioceltix do? Bioceltix SA focuses on research and development within the field of veterinary medicine, specifically targeting the treatment of companion animals. The company develops candidates for veterinary medicinal products by utilizing the immunomodulatory properties of mesenchymal stem cells as the active substance. This scientific approach allows the firm to conduct research and development works that facilitate clinical trials and the full registration of these medicinal products with the European Medicines Agency, adhering to standards similar to those for human medicines. Bioceltix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioceltix stock

On Eulerpool you can find the complete historical development of Fixed Asset Turnover Bioceltix since 2006 – with annual values, charts, and detailed analysis.

Fixed asset turnover measures revenue generated per unit of PP&E. Higher ratios indicate more efficient utilization of physical assets.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Fixed Asset Turnover's Bioceltix with sector peers and the industry average to assess whether it is attractive.

To evaluate Fixed Asset Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Fixed Asset Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Bioceltix

All Key Metrics — Bioceltix